Anticancer drugs with targeted therapy at the p450-mediated tumor metabolism site can be an important addition to anticancer therapy; moreover, targeted therapy against the polymorphic C site can be a promising therapy in future cancer therapy studies [35]. Here, CYP2B6 is linked to cancer.